Colgate-Palmolive Company (NYSE:CL) has a 1 Year Target Estimate of $76.56. The stock traded with the volume of 2.67 Million in the last trading session. Colgate-Palmolive Company opened at $66.65 and closed by showing an increase of 0.15%. The Bid price in the last session was $65.50 x 200 and the Ask price was $66.75 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).
Colgate-Palmolive Company has the Market Capitalization of 59.13 Billion. The Stock has its 52-week High of $75.38 and 52-Week Low of $61.4 and it touched its 52-week high on Aug 12, 2016 and 52-Week Low on Jan 20, 2016.
Colgate-Palmolive Company reported its last Earnings on Oct 27 BMO where the company reported Actual EPS of $0.73/Share whereas, the Analyst Estimated EPS was $0.73/share. The difference between Actual EPS and Estimated EPS was $0/share. This represented an Earnings Surprise of 0%. The company will report its next earnings on 27-Jan-17.
Some analyst provided their insight on Growth Estimates; Colgate-Palmolive Company has the Current Quarter Earnings Growth rate of 4.1%. The Next Quarter growth is expected to be 12.7%. In the past 5 years, the stock has earnings growth rate of 1.6% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 8.48% per annum.
16 number of analysts also provided their insight on Colgate-Palmolive Company, where the Average Price Target for the stock is $76.56. They also projected Low Price Target as $70 while High Price Target is set at $85.
A number of analysts rated the stock as well: 2 analysts believe that the stock is a STRONG BUY while 2 reported it as Buy.18 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.
Colgate-Palmolive Company annual Divided is 1.56 while it’s Dividend Yield is 2.34%. The stock has its Price to Earnings (P/E) ratio of 43.54 and Forward Price to Earnings ratio of 21.81. The company has its Price to Sales (P/S) ratio of 3.85 where Price to Book (P/B) ratio of 0, Price to Cash Per share (P/C) of 39.79 and Price to Free Cash Flow (P/FCF) has a value of 57.92.
The company has its Return on Assets (ROA) of 11.1 Percent. Return on Equity (ROE) stands at -508.6% and Return on Investment (ROI) displays a value of 25.2%.
The stock is currently trading at Distance from 20-Day simple moving Average of -2.45% whereas, Distance from 50-Day Simple moving average is -5.69 Percent and Distance from 200-Day Simple Moving Average of -5.99 percent.
A look at performance overview of Colgate-Palmolive Company depicts that Performance (Week) is 0.47 percent while Performance Month is -6.52%. Quarterly performance shows a value of -10.21% and Half Year Performance value stands at -5.55%. Yearly performance of the stock has the value of 3.57 percent. Colgate-Palmolive Company has its YTD performance of 2.11 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).
Many Insiders have done trades inside the company. The latest trade was made on 14 Nov 2016 where Chief Technology Officer Verduin (Patricia Ph.D.) did a transaction type “Buy” in which 3834 shares were traded at a price of $45.23. Another insider trade includes Chief Technology Officer Verduin (Patricia Ph.D.) who also initiated a transaction in which 3834 shares were traded on 14 Nov 2016 as “Sell”. On 16 Oct 2016 Chief Technology Officer Verduin (Patricia Ph.D.) traded 3834 shares as “Buy” at $45.23. Director Bilbrey (John P) Buy 256 shares on 2 Oct 2016 at the price of $73.08.
The latest Upgrades/Downgrades was done by Research firm BofA/Merrill on 12-Sep-16 who Upgrade the stock from Neutral to Buy. Other firms have also Upgraded/Downgraded the stock. On 29-Jul-16, Exane BNP Paribas took an action “Downgrade” from Outperform to Neutral. On 2-May-16, the stock was Upgrade to Neutral by Goldman.